Concomitantly, we performed numerous experiments, including cell proliferation, colony formation, cell cycle and apoptosis, cell motility, migration and invasion tests, to assess the effect of IL-22 on the proliferation and invasiveness of BC cell lines MDA-MB-231 and MCF7. Here, IL22 is linked to breast cancer.